PFIZER RECEIVES ZOLOFT OCD INDICATION WITHOUT DOSE-RESPONSE RELATIONSHIP; FIRM HAS SUBMITTED PROPOSED CORRECTIVE PLAN IN RESPONSE TO FDA WARNING LETTER

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".